Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors-Reference-Cited by-同舟云学术

Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors

Published:2010-06-11 Issue:13 Volume:53 Page:4891-4905
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ferreira Rafaela S.¹²³,Simeonov Anton⁴,Jadhav Ajit⁴,Eidam Oliv²,Mott Bryan T.⁴,Keiser Michael J.²,McKerrow James H.³,Maloney David J.⁴,Irwin John J.²,Shoichet Brian K.²

Affiliation:

1. Graduate Program in Chemistry and Chemical Biology

2. Department of Pharmaceutical Chemistry

3. Sandler Center for Basic Research in Parasitic Diseases

4. NIH Chemical Genomics Center, Bethesda, Maryland 20892-3370

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm100488w

Reference59 articles.

1. Exploring biology with small organic molecules

2. Navigating chemical space for biology and medicine

3. Detailed Analysis of Scoring Functions for Virtual Screening

4. Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-Lactamase

5. Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure‐Metabolism Relationships of Benzimidazole Derivatives with anti‐Trypanosoma cruzi Activity for Chagas Disease;ChemMedChem;2024-08-27

2. ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery;Nucleic Acids Research;2024-05-23

3. A Mild and Eco-friendly, One-pot Synthesis of 2-hydroxy-Narylacetamides from 2-chloro-N-arylacetamides;Letters in Organic Chemistry;2024-05

4. Integrated Computational Approaches for Drug Design Targeting Cruzipain;International Journal of Molecular Sciences;2024-03-27

5. Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges;Drug Resistance Updates;2024-03